<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00565006</url>
  </required_header>
  <id_info>
    <org_study_id>0859-012</org_study_id>
    <secondary_id>2007_656</secondary_id>
    <nct_id>NCT00565006</nct_id>
  </id_info>
  <brief_title>A Study to Investigate the Influence of MK0859 on Blood Pressure (MK-0859-012)(COMPLETED)</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Merck Sharp &amp; Dohme Corp.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Merck Sharp &amp; Dohme Corp.</source>
  <brief_summary>
    <textblock>
      This study will investigate the influence of MK0859 on ambulatory blood pressure, and how
      safe and tolerable MK0859 is on the subjects This is an early phase trial and some specific
      protocol information is in progress and not publicly available at this time. (Full
      information is available to trial participants).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2006</start_date>
  <completion_date type="Actual">September 2006</completion_date>
  <primary_completion_date type="Actual">September 2006</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <enrollment type="Actual">22</enrollment>
  <condition>Ambulatory Blood Pressure</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>MK0859</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  You are between the ages of 45-75

          -  You are a man or non-pregnant woman

          -  You agree to not eat or drink fruit or fruit juices (orange, apple or grapefruit) for
             2 weeks before starting study medication

        Exclusion Criteria:

          -  You have smoked or used other nicotine-containing products (chewing tobacco) within
             the last 6 months

          -  You have used St. John's Wort or any products that include it within the last 2 weeks

          -  You have used herbal, organic, dietary or nutritional remedies within the last 2 weeks

          -  You have a history of drug allergies (anaphylaxis, angioedema)

          -  You have taken an investigational drug in another clinical trial within the last 4
             weeks

          -  You have a history of cardiovascular disease including hypertension (high blood
             pressure)

          -  You have a history of renal disease

          -  You have a history of gall bladder disease or have had abnormal liver function tests

          -  You have a history of drug or alcohol abuse

          -  You drink more than 6 cups of caffeinated beverages a day (coffee, tea or cola)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Medical Monitor</last_name>
    <role>Study Director</role>
    <affiliation>Merck Sharp &amp; Dohme Corp.</affiliation>
  </overall_official>
  <verification_date>February 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 27, 2007</study_first_submitted>
  <study_first_submitted_qc>November 27, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 29, 2007</study_first_posted>
  <last_update_submitted>February 25, 2015</last_update_submitted>
  <last_update_submitted_qc>February 25, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 27, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anacetrapib</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

